American Society of Hematology sponsors high school symposium at San Diego annual meeting

December 05, 2003

(San Diego, Calif., December 5, 2003) - The American Society of Hematology, in conjunction with its 45th Annual Meeting, will host an interactive half-day symposium today for more than 200 local high school students. Designed to spark interest in the fields of science and medicine and expose students to career opportunities, the symposium features lecture sessions and hands-on exhibits with leading experts in the field of hematology. Today's symposium will take place at the San Diego Convention Center from 9:00 a.m. to 1:00 p.m.

In its ninth year, the symposium provides high school students and teachers with a unique opportunity to learn from specialists in science and medicine in an interactive forum. During the program, participants attend four sessions: two hands-on exhibit sessions and two lecture sessions, which consist of presentations, question and answer time, and informal small group discussions. This year, Renate Pilz, M.D., of the University of California - San Diego, will speak on the subject of bone marrow stem cells and leukemias, and Michael Bender, M.D., of the Fred Hutchinson Cancer Research Center, will discuss sickle cell disease. At their booths, exhibiting organizations Chrono-log, Amgen, Wyeth Oncology, OrthoBiotech, The Scripps Research Institute, and IMPATH will feature interactive displays, experiments, and hands-on projects.

For the second year in a row, ASH is sponsoring a poster and essay contest to encourage innovation among students. Competing high school teams will conduct research on symposium topics and showcase their collective methods and findings. Presentations are judged based on information accuracy, the amount of information presented, and the level of creativity involved. Cash prizes are awarded for the top four posters. "Last year's poster and essay contest proved to be a great success," said Beverly Torok-Storb, Ph.D., of the Fred Hutchinson Cancer Research Center. "Not only did the contest encourage interaction between experts and students, it also forced students to bring their scientific ideas to life and think critically about current issues in a proactive manner."

The American Society of Hematology's 45th Annual Meeting, to be held December 6-9, 2003, at the San Diego Convention Center, provides hematologists from around the world a forum for discussing critical issues in hematology. Nearly 20,000 clinicians, scientists, and others attend the four-day meeting, which consists of a superb educational program and cutting-edge scientific sessions. For more information, please visit
The American Society of Hematology (ASH), founded in 1958, works to further the understanding, diagnosis, treatment, and prevention of disorders affecting the blood, bone marrow, and the immunologic, hemostatic and vascular systems, by promoting research, clinical care, education, training, and advocacy in hematology.

For more information about ASH, call (202) 776-0544, or visit

The American Society of Hematology is the world's largest professional society concerned with the causes and treatment of blood disorders. Its mission is to further the understanding, diagnosis, treatment, and prevention of disorders affecting blood, bone marrow, and the immunologic, hemostatic, and vascular systems, by promoting research, clinical care, education, training, and advocacy in hematology.

American Society of Hematology

Related Hematology Articles from Brightsurf:

Study finds gender disparities in hematology research success
Hematologists who complete a mentored training program experience greater levels of academic success than those who do not; however, a study published today in Blood Advances suggests a slight discrepancy in success levels between male and female hematologists.

Survey suggests mentorship in medical school is vital to future of hematology
A survey of US hematology-oncology fellows suggests medical school plays an important role in shaping their interest in pursuing careers in hematology, particularly when students are exposed to hematology and oncology as part of core clerkships in internal medicine and pediatrics.

JAK inhibitors associated with aggressive lymphoma
Austrian researchers have discovered that a small number of patients taking targeted drugs known as Janus kinase (JAK) inhibitors to treat myelofibrosis may develop aggressive lymphomas.

For young adults with blood cancer, pediatric centers may improve survival
Adolescents and young adults with acute leukemia have a survival advantage if they receive treatment at a pediatric cancer center versus an adult center, according to a new study.

Global hematology diagnostics market estimated to expand at a robust CAGR over 2021
Hematology includes various IVD technologies such as blood analysis, flow cytometry, immunodiagnostics, molecular diagnostics, hemostasis, histology, and cytology.

Late-breaking hematology abstracts signal new, near-term therapeutic options for patients
In four clinical trials being presented today during the 59th American Society of Hematology (ASH) Annual Meeting and Exposition in Atlanta, researchers report promising results suggesting patients with blood disorders and several types of cancer will soon have significantly expanded options for treatment.

American Society of Hematology announces top trainee abstracts of 2016 ASH Annual Meeting
The American Society of Hematology (ASH) is pleased to recognize the following trainees with the highest-scoring abstracts in the categories of undergraduate student, medical student, graduate student, resident physician, and postdoctoral fellow at the 58th ASH Annual Meeting Dec.

ASH to expand family of blood journals with launch of new cutting-edge publication
The American Society of Hematology (ASH) will launch an open-access journal to complement Blood, its flagship publication and the most-cited journal in hematology.

Study finds common genetic variants that double risk for blood clots in African Americans
New research published online today in Blood the Journal of the American Society of Hematology, identifies common genetic variants predominantly found in African Americans that double their risk for blood clots.

Mount Sinai researchers present results at American Society of Hematology Meeting
Icahn School of Medicine at Mount Sinai researchers will present several landmark studies at the 2015 American Society of Hematology meeting Dec.

Read More: Hematology News and Hematology Current Events is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to